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infection control is highly needed in long term care facilities in Japan, and
the nurses are struggling to find the appropriate methods and systems.
In this symposium, I would like to introduce the types of long term care
facilities in Japan, and present some infection control trials in the long term
care facilities.SP 18-3
LONG TERM CARE FACILITIES SYSTEM IN TAIWAN
Shyh-Dye Lee, M.D., M.P.H. Graduate Institute of Long-Term Care, National
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Long-term care (LTC) in Taiwan is grossly under developing and processing.
Policy making and financing arrangements for LTC are now important and hot
in Taiwan. In Taiwan, formulation of policy (and related programmes)
objectives has progressed considerably ever since two decades before. The
necessary social value system, working model, service scheme, delivery
system, legal framework, and LTC worker & manager repositioning and
nurturing, even establishing related certificate/licensure of the new disci-
pline of care worker/management have been still under developing, but well
focusing on related administrative supervising and accreditation on some
related practices or delivery. Newly LTC Service Act and LTC Insurance Act
legislation are still under-going in the congress (Legislative Yen) contempo-
rarily. The basis of financing arrangements, pension system besides, LTC
Insurance(LTCI) taskforce has been under planning at present. LTC demands/
needs will exceed supply tremendously as expected, the resource deficit gap
will be expected to deepen after LTCI launching then. Developing LTCI scheme
is now a central headline for policy formulation, and government continues to
take a leading role in consolidating financing and integrating the service
systems. Now, people have only taken the roughmessage about LTC insurance
launching in 2016(hopefully). For the processing of LTC globally, LTC facility is
originally a place/site of collective accommodation & living where care on the
activities even participations of those in needs is provided as a package. It
refers to a specially designed setting where the services are provided for
people with functional limitations/restrictions, mostly for those with moder-
ately to severely impaired/dependent. In Taiwan, those with LTC needs have
been well set in facility or non-facility scheme whatever still low relatively.
LTC in facility (institutionalized care) has taken majority of LTC needs
initially; current measures are concerned to facilitate the expansion of
home-based or community-based rather than institutionalized care, rather,
organizing the specific patterns of LTC, such as dementia care.
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FUNGAL INFECTIONS AND ENVIRONMENTSP 19-1
THINK FUNGUSdPREVENTION AND CONTROL OF FUNGAL INFECTIONS
Tom M. Chiller. Centers for Disease Control and Prevention, United StatesSP 19-2
THE MOLECULAR EPIDEMIOLOGY OF HUMAN FUNGAL PATHOGENS
Shu-Ying Li. Centers for Disease Control, Ministry of Health and Welfare,
TaiwanSP 19-3
INSIGHTS INTO CRYPTOCOCCAL MENINGITIS IN HIV-UNINFECTED CHINESE
PATIENTS
Liping Zhu. Department of Infectious Diseases, Huashan Hospital, Fudan
University, Shanghai 200040, China
Cryptococcus neoformans (C. neoformans ) is the most common cause of
fungal infections of the central nervous system in immunocompromisedpatients with or without AIDS. However, cryptococcal meningitis in appar-
ently healthy individuals is also increasingly being reported, especially
from Asia. This raises the question of whether the so-called healthy hosts
are, in fact, accompanied with genetic immune predispositions. Host im-
mune responses are initiated by pattern recognition receptors (PRRs),
including Toll-like receptors (TLRs), C-type lectin receptors (CLRs), NOD-
like receptors (NLRs), and others. In the last years, several studies have
identified genetic polymorphisms in these receptors to be associated with
susceptibility to C. neoformans. Here, we review the contribution of genetic
polymorphisms of the PRRs to susceptibility to C. neoformans infection and
some of our genetic studies are included.
SYMPOSIUM 20 (SP 20)
ENVIRONMENTAL CLEANING FOR MDRO CONTROLSP 20-1
CONTROL OF MULTIDRUG RESISTANT GRAM-POSITIVE BACTERIA:
LESSONS FROM RECENT INTERVENTIONAL STUDIES IN ICUS
Stephan Harbarth. Infection Control Program, Geneva University Hospitals,
Geneva, Switzerland
Several major trials published last year questioned the effectiveness of
universal screening and contact precautions in controlling MRSA. These trials
generally recommend universal decolonization as part of bundles to control
MRSA, especially in ICUs, with some even concluding that universal
decolonization should replace active screening and contact precautions.
However, emerging resistance to agents used for decolonization, such as
mupirocin and chlorhexidine, is a major concern. Several other studies
confirmed a combination of hand hygiene enhancement, screening, contact
precaution and targeted decolonization as a more viable MRSA infection
control strategy for specific population groups.
In summary, universal decolonization is an acceptable MRSA control strategy
for intensive care units; however, close monitoring of chlorhexidine and
mupirocin resistance is warranted. As a strategy, screening and contact
precautions are suitable for hospital-wide MRSA control. Targeted decolo-
nization is a proven measure for patients undergoing clean surgery.
Enhancement of hand hygiene is a core measure regardless of the strategy.SP 20-2
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The 2003 SARS epidemic resulted in a systemic renovation for the strategy of
infection control, aiming to approach the goal of zero tolerance instead of
3e5% healthcare-associated infection (HAI) rate. Among those infection
control measures and processes, hand hygiene campaign is the most cost-
effective and widely accepted practice in HAI prevention. Although hand
hygiene campaign has been promoted in Taiwan with limited success,
environmental issue was still ignored as insignificant factor of HAIs. However,
the cross transmission of pathogens to patients occurred not only result
directly from hands of healthcare workers, but also from indirect contact of
hospital environment or patient’s surroundings. Studies from SARS epidemic
and outbreaks of healthcare-associated multidrug-resistant organisms
(MDROs), such as carbapenem-resistant Acinetobacter baumannii and vanco-
mycin-resistant enterococci, have raised the new scope to examine the
importance of environmental impact, that is, fomites transmission, when
the goal of infection prevention was set at zero tolerance besides of outbreak
control. There were several studies regarding the control of fomites transmis-
sion through additional environmental disinfection around patient’s beds and
surroundings. However, there have always been the questions of quality insta-
bility and inconsistency for the manual cleaning and disinfection process.
Recent advancements in medical nanotechnology may play a major role in
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compared with those of manual cleaning and disinfection, which include chlo-
ride such as slightly acidic hypochlorous acid water or titanium dioxide. Of
them, Bio-Kil (Cargico Group, Taiwan) is a platform nanotechnology with con-
struction of quaternary ammonium compound to create a covalent or ionic
bond and embedded into the surfaces of environment, forming a durable
copolymer with a physical bactericidal property. A pilot study in intensive
care units had shown that the BIO-Kil treatment can inhibit the growth of bac-
teria and evidently suppress its colonization from 49.62 to 10.38 CFU/10 cm2.
Today we will present further study of its effectiveness on controlling the
colonization of MDROs in the hospital settings. Together with hand hygiene
campaign and other infection control bundles, there is a new horizon for us
to achieve the zero tolerance of HAIs in the 21st century.SP 20-3
PROACTIVE INFECTION CONTROL MEASURES TO PREVENT NOSOCOMIAL
TRANSMISSION OF VRE
Vincent C. C. Cheng a,b, S. C. Wong b, K. Y. Yuen b. aInfection Control Team,
Queen Mary Hospital, Hong Kong Special Administrative Region;
bDepartment of Microbiology, The University of Hong Kong, Hong Kong
Special Administrative Region
We adopted a multifaceted assertive proactive infection control approach
to minimize the nosocomial transmission and outbreak of VRE in a non-
endemic area. Active surveillance culture, extensive contact tracing and
single room isolation with contact precautions, together with other
infection control measures, such as directly observed hand hygiene in
conscious patients before receiving meals and medications, stringent hand
hygiene during patient care practices, and environmental cleanliness are
essential in limiting intra- and inter-hospital transmission. With the
implementation of these infection control measures, the incidence of
nosocomial acquisition of VRE had significantly decreased from 0.46 per
10,000 patient-days to 0.10 per 10,000 patient-days (p < 0.001 under
Poisson assumptions).
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BENEFITS OF ANTIMICROBIAL STEWARDSHIP IN HOSPITALS: EVIDENCE
FROM A RECENT COCHRANE REVIEW
Ian M. Gould. Department of Medical Microbiology, Aberdeen Royal
Infirmary, Foresterhill, Aberdeen, Scotland AB25 2ZN, United Kingdom
Antibiotic stewardship has been around now for several decades but has
received renewed focus as a means of slowing the development of antibiotic
resistance (AR). Cochrane reviews include only papers of sufficiently robust
methodology and at the date of the last review (2006) there were less than
100 published scientific papers so classified on Antibiotic Stewardship. In
recent years a greater proportion of published papers have been included
but almost all are from USA and Europe. The majority use interrupted time
series analysis, with about a quarter being randomised controlled trials.
Currently a new review is updating the data basis and I will include data from
many of these papers in this talk.
Restrictive interventions such as order forms and expert approval have a
more immediate effect than persuasive (educational) interventions such as
audit and academic detailing but the effects of both are well maintained
over at least 2 years. Most are delivered by multidisciplinary teams, followed
by ID/micro and pharmacists.
There is robust evidence that effective stewardship, leading to major
reduction (34-42%) in the use of key agents such as quinolones and
cephalosporins can reduce Clostridium difficile infection, MRSA, VRE and
multi resistant Gram negatives by 24-68%. Lessons can be learnt from this
data for the control of carbapenemases. Also, improved quality of
use can reduce mortality from CAP. No associated increases in
mortality, length of stay or infection specific re-admission have been
documented.
In summary, antibiotic stewardship has a valuable role to play, alongside
hand hygiene and surveillance/cohorting/isolation/suppression/decoloniza-
tion in the control of Multi-Drug Resistant Organisms (MDROs).SP 21-2
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SUSTAINABILITY: A CASE STUDY OF ANTIBIOTICS SMART USE PROGRAM
IN THAILAND
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Purpose: The ability to scale up health programs after the pilot project or
seeding funds ended has gained interest from health professionals, policy
makers and funders. Lessons learned from the Antibiotics Smart Use (ASU)
program might be useful. ASU aims at reducing antibiotic use in upper respi-
ratory infection, acute diarrhea and simple wound. Phase I tests interven-
tions (2007-8). Phase II assesses scaling-up feasibility (2008-9). Phase III
scales up ASU toward sustainability to achieve new social norms (2010-pre-
sent). The study aims at investigating ASU diffusion, scaling-up measures
and factors contributing to ASU adoption and sustainability.
Methods: ASU diffusion and factors regarding ASU adoption was assessed by
a mailed, self-administered survey for all hospitals. Scaling-up measures and
factors contributing to ASU continuity were assessed using previous ASU
evaluation research and in-depth interviews of 50 key informants from 15
ASU settings. Data were collected during MayeOctober 2014.
Results: Of 625 hospitals (response rate 52%), 91% were aware of ASU and
72% implemented ASU. The ASU adoption rate was 3% in 2008 and increased
to 17%, 25% and 27% during 2010-2012. Scaling up started with a model devel-
opment and followed by horizontal and vertical scaling-up measures. Hori-
zontal measures included building decentralized networks to promote
local ownerships. Vertical measures focused on integrating ASU into national
policies. The pay-for-performance policy by the National Health Security Of-
fice in 2009 greatly induced scaling-up. Factors involving ASU adoption
included to solve irrational use of medicines, to do the right thing, and to
improve quality of care. ASU continuity required ASU prime mover(s), man-
agement in hospitals, and external factors especially national policies.
Conclusion: ASU scaling-up starts with a model development and follows by
horizontal and vertical scaling-up measures. Despite limited resources, ASU
continues scaling up but its sustainability remains challenging as it needs
strong, long-term support from relevant national policies.SP 21-3
HOSPITAL INITIATIVES
Ching-Tai Huang. LinKou Chang Gung Memorial Hospital, Taiwan
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AN INTERNATIONAL APPROACH TO ANTIMICROBIAL STEWARDSHIP:
EXAMPLE FROM VIETNAM
Heiman Wertheim, MD PhD. Oxford University Clinical Research Unit, Viet
Nam
Antimicrobial resistance is a major global health threat. In the European
Union an estimated 25,000 deaths occur annually secondary to multi-drug-
resistant infections. No reliable estimates for developing countries exist, but
figures are likely to be higher. Strategies to contain antimicrobial resistance
were comprehensively set forth by the World Health Organization (WHO) in
2001. However, implementation in low- and middle-income countries, where
the need for effective antimicrobials is greatest, has thus far proved
problematic [3],[4].
In Viet Nam, where resistance rates are among the highest in Asia, the
challenge is urgent and great. A large population, high infectious disease
burden, and unrestricted access to antimicrobials make Viet Nam a hotspot
for the emergence of drug resistance. Adequate legislation to tackle
antimicrobial resistance in Viet Nam already exists, but a lack of resources
prevents effective policy enforcement.
